## Abstract This is a commentary on a Cochrane review, published in this issue of EBCH, published as: Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen‐positive mothers. __Cochrane Database of Systematic Reviews__ 2006, Issue 2. A
Cochrane review: Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers
✍ Scribed by C Lee; Dr Y Gong; J Brok; EH Boxall; C Gluud
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 645 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1557-6272
- DOI
- 10.1002/ebch.120
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Serum hepatitis B surface antigen (HBsAg) levels may reflect the immunomodulatory efficacy of pegylated interferon (PEG-IFN). We investigated within a large randomized trial whether quantitative HBsAg levels predict response to PEG-IFN in patients with hepatitis B e antigen (HBeAg)-positive chronic
## Abstract It is well known that fulminant hepatitis B can occur in infants born to hepatitis B e antigen (HBeAg)‐negative hepatitis B virus (HBV) carrier mothers, whereas fulminant hepatitis and severe hepatitis are uncommon in infants born to HBeAg‐positive mothers. We have encountered an infant
## Abstract It is well documented that perinatal transmission is the major cause of chronic HBV infection in China. However, the mechanisms of HBV perinatal transmission are not defined clearly. It is not known whether hepatitis B e antigen can cross the human placenta, and the rate of HBeAg decay